What is the recommended treatment for recurrent pericarditis?

Treatment for Recurrent Pericarditis

First-line treatment for recurrent pericarditis is high-dose aspirin or NSAIDs combined with colchicine for at least 6 months, plus exercise restriction until symptoms resolve and CRP normalizes. 1

First-Line Therapy (Class I Recommendation)

The cornerstone of treatment combines:

• Aspirin or NSAIDs at full anti-inflammatory doses (Class I, Level A):

  • Aspirin: 500-1000 mg every 6-8 hours (1.5-4 g/day total)
  • Ibuprofen: 600 mg every 8 hours (1200-2400 mg/day total)
  • Indomethacin: 25-50 mg every 8 hours
  • Continue until complete symptom resolution
  • Taper by 250-500 mg (aspirin) or 200-400 mg (ibuprofen) every 1-2 weeks 1

• Colchicine (Class I, Level A):

  • 0.5 mg once daily if <70 kg body weight
  • 0.5 mg twice daily if ≥70 kg body weight
  • Minimum duration: 6 months (longer if needed based on clinical response)
  • No loading dose for recurrent episodes
  • This reduces recurrence from 37.5% to 16.7% 1, 2

• Exercise restriction:

  • Non-athletes: Until symptom resolution and CRP normalization
  • Athletes: Minimum 3 months until symptoms resolve AND CRP, ECG, and echocardiogram normalize 1

Monitoring and Tapering Strategy

Use CRP levels to guide treatment duration and tapering decisions (Class IIa, Level C). Only attempt tapering when the patient is asymptomatic AND CRP is normal. Taper one drug class at a time, stopping NSAIDs/aspirin first before gradually discontinuing colchicine over several months in difficult cases 1.

Second-Line Therapy: Low-Dose Corticosteroids

Corticosteroids should only be used when there are contraindications to NSAIDs/colchicine OR incomplete response to first-line therapy, and ONLY after excluding infectious causes (particularly tuberculosis and bacterial infections) 1.

Critical caveat: Corticosteroids provide rapid symptom control but significantly increase recurrence rates, promote chronicity, and cause drug dependence. They should be avoided as first-line therapy 1.

When corticosteroids are necessary:

• Prednisone 0.2-0.5 mg/kg/day (low to moderate dose)
• Add as triple therapy with NSAIDs and colchicine—do not replace these drugs
• Use very slow tapering, especially below 15 mg/day prednisone:

  • 50 mg: decrease by 10 mg every 1-2 weeks

  • 50-25 mg: decrease by 5-10 mg every 1-2 weeks
  • 25-15 mg: decrease by 2.5 mg every 2-4 weeks
  • <15 mg: decrease by 1.25-2.5 mg every 2-6 weeks 1
• Provide calcium (1200-1500 mg/day) and vitamin D (800-1000 IU/day) supplementation
• Consider bisphosphonates for men ≥50 years and postmenopausal women on ≥5-7.5 mg/day prednisone 1

If symptoms recur during tapering: Do NOT increase corticosteroid dose. Instead, maximize NSAIDs (every 8 hours, IV if necessary), ensure colchicine is added, and use analgesics for pain control 1.

Third-Line Therapy: IL-1 Inhibitors and Immunosuppressants

For corticosteroid-dependent recurrent pericarditis not responsive to colchicine (Class IIb, Level C), consider:

• IL-1 inhibitors (preferred based on recent evidence):

  • Anakinra or rilonacept
  • Dramatically reduce recurrences (10% vs 78% with placebo) 3
  • Recent real-world data shows IL-1 inhibitors increasingly replace corticosteroids as second-line therapy, with 64% of patients now receiving IL-1 inhibition as second-line treatment after 2023 4
  • Particularly valuable for patients with multiple recurrences, high inflammatory burden, or those at high risk for corticosteroid complications 5, 6, 7

• Alternative immunosuppressants:

  • Azathioprine (less expensive option)
  • IVIG (immunomodulatory and anti-viral)
  • Require consultation with immunologists/rheumatologists 1

Important: Educate patients about clinical risks of immunomodulatory/immunosuppressive drugs and necessary safety measures 1.

Fourth-Line: Pericardiectomy

Consider pericardiectomy only as a last resort after thorough trial of unsuccessful medical therapy, with referral to a center with specific surgical expertise 1. This is reserved for cases progressing to constrictive pericarditis despite optimal medical management 8.

Common Pitfalls to Avoid

1. Starting corticosteroids too early: This is the single biggest mistake—it increases recurrence rates and creates steroid dependence 1
2. Inadequate colchicine duration: Must continue for at least 6 months, often longer 1
3. Rapid corticosteroid tapering: The 10-15 mg/day prednisone threshold is critical—taper very slowly at this level 1
4. Increasing corticosteroids during recurrence: Maximize NSAIDs instead 1
5. Not excluding infection before starting corticosteroids: Particularly tuberculosis in endemic areas 1, 2
6. Premature return to exercise: Athletes need minimum 3 months restriction 1